Cordatus Wealth Management LLC

Position in ABBV — AbbVie Inc.

CIK 1715862 NEWTOWN, PA

Position in ABBV

as of Jun 30, 2026 · filed Jul 29, 2026 Compact

Position Value

$4,128,154

+$565,668 QoQ

Shares Held

16,405

+0.2% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

1.23%

of 13F equity value

Holder Rank

#1,433

of 4,153 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Cordatus Wealth Management LLC holds $25,634,141 across 8 Drug Manufacturers - General names. ABBV ranks #3 (16.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	32,020	$8,132,119
2	LLY	ELI LILLY & Co	4,307	$5,165,945
3	ABBV	AbbVie Inc. This page	16,405	$4,128,154
4	MRK	Merck & Co., Inc.	29,906	$3,842,921
5	AMGN	Amgen Inc	8,245	$2,985,679
6	NVS	Novartis AG	4,593	$719,814
7	AZN	Astrazeneca PLC	1,920	$364,070
8	GSK	GSK plc	5,636	$295,439

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,128,154	16,405	+0.2%	Shares	Sole	2026-07-29
2026-03-31	$3,562,486	16,380	-1.4%	Shares	Sole	2026-04-29
2025-12-31	$3,794,076	16,605	+0.0%	Shares	Sole	2026-01-26
2025-09-30	$3,844,027	16,602	+0.6%	Shares	Sole	2025-10-22
2025-06-30	$3,062,730	16,500	-0.0%	Shares	Sole	2025-08-11
2025-03-31	$3,458,546	16,507	+3.3%	Shares	Sole	2025-05-08
2024-12-31	$2,839,646	15,980	+4.2%	Shares	Sole	2025-02-03
2024-09-30	$3,028,948	15,338	+1.0%	Shares	Sole	2024-10-28
2024-06-30	$2,605,731	15,192	+16.0%	Shares	Sole	2024-07-18
2024-03-31	$2,384,053	13,092	+0.5%	Shares	Sole	2024-04-30
2023-12-31	$2,018,019	13,022	-11.1%	Shares	Sole	2024-01-17
2023-09-30	$2,183,430	14,648	-1.0%	Shares	Sole	2023-10-31
2023-06-30	$1,994,138	14,801	+694.5%	Shares	Sole	2023-07-14
2023-03-31	$296,906	1,863	0.0%	Shares	Sole	2023-05-03
2022-12-31	$301,079	1,863	—	Shares	Sole	2023-02-06
No filing history on record for this holder in this stock.